TNFSF10 and cancer: The distinct ability of triggering apoptosis in many types of human cancer cells while sparing normal cells makes TRAIL an attractive agent for cancer therapy, however, resistance to TRAIL-mediated apoptosis in cancer cells is a limitation in its clinical application as a cancer therapeutic agent.